UTHR Price / Book | United Therapeutics Corporation

United Therapeutics Corporation (UTHR) Price / Book

2026-09-03: Price/Book Ratio 3.29.
2026-06-30: Price/Book Ratio 3.61.
2026-03-31: Price/Book Ratio 4.24.
2025-12-31: Price/Book Ratio 3.

Historical market capitalization divided by filed shareholder equity.

Available history: 2009-12-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	3.29
2026-06-30	3.61
2026-03-31	4.24
2025-12-31	3
2025-09-30	2.73
2025-06-30	1.81
2025-03-31	2.04
2024-12-31	2.45
2024-09-30	2.62
2024-06-30	2.48
2024-03-31	1.9
2023-12-31	1.73
2023-09-30	1.86
2023-06-30	1.91
2023-03-31	2.04
2022-12-31	2.67
2022-09-30	2.09
2022-06-30	2.48
2022-03-31	1.95
2021-12-31	2.46
2021-09-30	2.17
2021-06-30	2.21
2021-03-31	2.17
2020-12-31	1.99
2020-09-30	1.37
2020-06-30	1.73
2020-03-31	1.42
2019-12-31	1.39
2019-09-30	1.29
2019-06-30	1.34
2019-03-31	2.22
2018-12-31	1.7
2018-09-30	2.07
2018-06-30	1.92
2018-03-31	2.06
2017-12-31	3.04
2017-09-30	2.45
2017-06-30	3.17
2017-03-31	2.95
2016-12-31	3.33
2016-09-30	2.74
2016-06-30	2.56
2016-03-31	2.92
2015-12-31	4.51
2015-09-30	4.08
2015-06-30	7.64
2015-03-31	7.32
2014-12-31	4.91
2014-09-30	5.17
2014-06-30	3.56
2014-03-31	3.55
2013-12-31	4.52
2013-09-30	3.14
2013-06-30	2.81
2013-03-31	2.66
2012-12-31	2.47
2012-09-30	2.7
2012-06-30	2.53
2012-03-31	2.47
2011-12-31	2.67
2011-09-30	2.02
2011-06-30	3.21
2011-03-31	4.21
2010-12-31	4.12
2010-09-30	3.78
2010-06-30	3.52
2009-12-31	4.37

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Viatris Inc (VTRS)	United States	$20.008B	-0.00
Royalty Pharma plc (RPRX)	United States	$22.628B
Jazz Pharmaceuticals plc (JAZZ)		$15.333B	16.07
Roivant Sciences Ltd. (ROIV)		$26.105B	-96.08
INSMED Inc (INSM)	United States	$26.566B	-26.60
Summit Therapeutics Inc. (SMMT)	United States	$13.071B	-13.21
BridgeBio Pharma, Inc. (BBIO)	United States	$12.947B	-20.72
CORCEPT THERAPEUTICS INC (CORT)	United States	$12.804B	169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)	United States	$11.879B	151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)	United States	$11.859B	-38.17